Switchable with visible light cisplatin analogs and complexes of selected transition metals - photochemical and anticancer activity in vitro
2021/41/B/NZ7/02484
Keywords
Descriptors
- ST4_012: Fotochemia
- ST4_011: Chemia koordynacyjna, supramolekularna
- NZ7_014: Farmacja, farmakoterapia, farmakologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Jagielloński, Wydział Chemii
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 6
Call
OPUS 21 – announced on 2021-03-15
- Amount awarded
- 1 655 646 PLN
- Project start date
- 2022-04-01
- Project end date
- 2027-03-31
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Light-Controlled Anticancer Activity and Cellular Uptake of a Photoswitchable Cisplatin Analogue
- Authors:
- Marta Stolarek, Kamil Kaminski, Marta Kaczor-Kamińska, Magdalena Obłoza, Piotr Bonarek, Anna Czaja, Magdalena Datta, Wojciech Łach, Mateusz Brela, Artur Sikorski, Janusz Rak, Maria Nowakowska, Krzysztof Szczubiałka*
- Academic press:
- Journal of Medicinal Chemistry (year: 2024, volume: 67, pages: 19103-19120), Publisher: American Chemical Society
- Status:
- Published
- DOI:
- 10.1021/acs.jmedchem.4c01575 – link to the publication